Create issue ticket

816 Possible Causes for V, topoisomerase

Show results in: 日本語

  • Meningitis

    The antinuclear antibodies (ANAs), antibodies to extractable nuclear antigens (ENAs), anti-native DNA antibodies (anti-DNA), topoisomerase I antibodies (Scl-70), antibodies[] An excellent coefficient of agreement was observed between V-CNS and routine assays [kappa index: 0.948 (95%CI: 0.928-0.968)].[] 37 Cytochrome P-450 CYP3A Inducers Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 38 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 39 Topoisomerase[]

  • Vibrio Cholerae O139

    In this study, mutations within the quinolone-resistance determining regions (QRDRs) of DNA gyrase and topoisomerase IV from NAL-resistant O139 strains were analysed.[] Eighteen (49%) of the 37 V. cholerae O1 patients were under 2 years of age compared with 6 (21%) of the 29 V. cholerae O139 patients (P 0.02).[] The linkages between 47 NotI and 32 SfiI fragments of V. cholerae SG24 genomic DNA were determined by combining two approaches: (i) identification of fragments produced by[]

  • Pentamidine

    All the compounds are able to bind with DNA and interfere in vitro with the activity of topoisomerase (I and II).[] We generated two binary models-the S100A5-RAGE V domain and S100A5-Pentamidine complex-and then observed that the pentamidine and RAGE V domain share a similar binding region[] The drug also inhibits topoisomerase enzymes in the mitochondria of Pneumocystis jirovecii .[]

  • Enoxacin

    Targets Topoisomerase II [1] Topoisomerase IV [1] In vitro Enoxacin, a fluoroquinolone used as an antibacterial compound, enhances the production of miRNAs with tumor suppressor[] Abstract Binding between vacuolar H -ATPases (V-ATPases) and microfilaments is mediated by an actin binding domain in the B-subunit.[] A mobile phase solvent consisting of 20 mm sodium dihydrogenphosphate (pH 3.0) and acetonitrile (85:15, v/v) was pumped at a flow rate of 1.0 mL/min.[]

  • Calotropis Procera

    The exposure of phosphatidylserine in apoptotic SK-MEL-2 was analysed by using the Annexin-V FITC flow cytometry method.[] The results of this study suggests that LP is a target for DNA topoisomerase I triggering apoptosis in cancer cell lines.[] Choedon T, Mathan G, Arya S, Kumar VL, Kumar V.[]

  • Vicia Faba

    topoisomerase II (IC50: 240-600 μM) activities.[] This is the first report of L. culinaris , V. faba and V. sativa as natural hosts of PNYDV in Austria and Germany.[] Quantification of v-c was done by spectrophotometry on the parents and the F(2 )population (n 136).[]

  • Nalidixic Acid

    Targets Topoisomerase II [1] Topoisomerase IV [1] Solubility (25 C) In vitro DMSO 6 mg/mL (25.83 mM) Water Insoluble Ethanol Insoluble * Please note that Selleck tests the[] Two well-known antibiotic heterocycles, the 'quinolone' nalidixic acid and the β-lactam penicillin V, active at different levels of the bacterial growth process, have been[] V. Polishchuk É. T. Karaseva T. B. Emelina Yu. M. Nikolenko V. E.[]

  • Leishmania

    topoisomerase I .[] (V.) naiffi cannot be as uncommon as previously thought or this species is currently expanding in this region.[] (V.) braziliensis. CD4 T-cells demonstrated their highest expression in ML and, in contrast, their lowest in ADCL.[]

  • Cefotaxime

    The occurrence and diversity of different genes conferring fluoroquinolone resistance [qepA, oqxAB, and aac(6')-Ib-cr] with mutations in topoisomerase-encoding genes (gyrA[] Female BALB/c mice were injected subcutaneously with 1 10(7) or 1 10(8) cfu of V. vulnificus.[] Point mutations in quinolone resistance determination regions of topoisomerases were identified in all the isolates, and most of the isolates accumulated three (n 78) or four[]

  • Mycoplasma Genitalium

    Mutations in the 23S rRNA gene can cause macrolide resistance, and topoisomerase/gyrase mutations can cause fluoroquinolone resistance.[] Macrolide-resistant strains have been shown to contain base substitutions in positions 2058 and 2059 (Escherichia coli numbering) in region V of the 23S rRNA gene.[] Previous studies have confirmed that single-base mutations at position 2058 or 2059 in domain V of the 23S rRNA gene of M. genitalium result in high-level macrolide resistance[]

Further symptoms